Selected research
Industry Growth & Trends
Global Pharmaceutical Decommissioning Service Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Pharmaceutical Decommissioning Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Pharmaceutical Decommissioning Service is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Pharmaceutical Decommissioning Service is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Pharmaceutical Decommissioning Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Pharmaceutical Decommissioning Service market include KDC Veolia, RCS Pharma, Technical Safety Services, ISPE, Brilliant Equipment Services, Qualitech Environmental Services, Hughes & Salvidge, Divestiture and Pharmagraph, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Pharmaceutical Decommissioning Service market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Pharmaceutical Decommissioning Service market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Pharmaceutical Decommissioning Service market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Pharmaceutical Decommissioning Service.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Pharmaceutical Decommissioning Service market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Pharmaceutical Decommissioning Service Market by Company
KDC Veolia
RCS Pharma
Technical Safety Services
ISPE
Brilliant Equipment Services
Qualitech Environmental Services
Hughes & Salvidge
Divestiture
Pharmagraph
RVA Group
DSM Demolition
KERAMIDA Inc
Downwell Enabling Solutions
Pharmaceutical Decommissioning Service Segment by Type
Equipment Decommissioning Service
Facility Decommissioning Service
Laboratory Decommissioning Service
Others
Pharmaceutical Decommissioning Service Segment by Application
Pharmaceutical Manufacturers
Pharmaceutical CDMO
Pharmaceutical Decommissioning Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharmaceutical Decommissioning Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pharmaceutical Decommissioning Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharmaceutical Decommissioning Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Pharmaceutical Decommissioning Service companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Equipment Decommissioning Service
- Facility Decommissioning Service
- Laboratory Decommissioning Service
- Others
Applications
- Pharmaceutical Manufacturers
- Pharmaceutical CDMO
Companies covered
- KDC Veolia
- RCS Pharma
- Technical Safety Services
- ISPE
- Brilliant Equipment Services
- Qualitech Environmental Services
- Hughes & Salvidge
- Divestiture
- Pharmagraph
- RVA Group
- DSM Demolition
- KERAMIDA Inc
- Downwell Enabling Solutions
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Pharmaceutical Decommissioning Service Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Pharmaceutical Decommissioning Service Market Size by Region (2021-2032)
- 1.4.1 Global Pharmaceutical Decommissioning Service Market Size by Region (2021-2026)
- 1.4.2 Global Pharmaceutical Decommissioning Service Market Size by Region (2027-2032)
- 1.5 Key Regions Pharmaceutical Decommissioning Service Market Size (2021-2032)
- 1.5.1 North America Pharmaceutical Decommissioning Service Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Pharmaceutical Decommissioning Service Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Pharmaceutical Decommissioning Service Market Size Growth Rate (2021-2032)
- 1.5.4 South America Pharmaceutical Decommissioning Service Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Pharmaceutical Decommissioning Service Market Size Growth Rate (2021-2032)
2 Pharmaceutical Decommissioning Service Market by Type
- 2.1 Type Introduction
- 2.1.1 Equipment Decommissioning Service
- 2.1.2 Facility Decommissioning Service
- 2.1.3 Laboratory Decommissioning Service
- 2.1.4 Others
- 2.2 Global Pharmaceutical Decommissioning Service Market Size by Type
- 2.2.1 Global Pharmaceutical Decommissioning Service Market Size Overview by Type (2021-2032)
- 2.2.2 Global Pharmaceutical Decommissioning Service Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Pharmaceutical Decommissioning Service Market Size Forecasted by Type (2027-2032)
- 2.3 Global Pharmaceutical Decommissioning Service Market Size by Regions
- 2.3.1 North America Pharmaceutical Decommissioning Service Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Pharmaceutical Decommissioning Service Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Pharmaceutical Decommissioning Service Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Pharmaceutical Decommissioning Service Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Pharmaceutical Decommissioning Service Market Size Breakdown by Type (2021-2026)
3 Pharmaceutical Decommissioning Service Market by Application
- 3.1 Type Introduction
- 3.1.1 Pharmaceutical Manufacturers
- 3.1.2 Pharmaceutical CDMO
- 3.2 Global Pharmaceutical Decommissioning Service Market Size by Application
- 3.2.1 Global Pharmaceutical Decommissioning Service Market Size Overview by Application (2021-2032)
- 3.2.2 Global Pharmaceutical Decommissioning Service Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Pharmaceutical Decommissioning Service Market Size Forecasted by Application (2027-2032)
- 3.3 Global Pharmaceutical Decommissioning Service Market Size by Regions
- 3.3.1 North America Pharmaceutical Decommissioning Service Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Pharmaceutical Decommissioning Service Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Pharmaceutical Decommissioning Service Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Pharmaceutical Decommissioning Service Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Pharmaceutical Decommissioning Service Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Pharmaceutical Decommissioning Service Industry Trends
- 4.2 Pharmaceutical Decommissioning Service Industry Drivers
- 4.3 Pharmaceutical Decommissioning Service Industry Opportunities and Challenges
- 4.4 Pharmaceutical Decommissioning Service Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Pharmaceutical Decommissioning Service Revenue (2021-2026)
- 5.2 Global Pharmaceutical Decommissioning Service Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Pharmaceutical Decommissioning Service Key Company Headquarters & Area Served
- 5.4 Global Pharmaceutical Decommissioning Service Company, Product Type & Application
- 5.5 Global Pharmaceutical Decommissioning Service Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Pharmaceutical Decommissioning Service Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Pharmaceutical Decommissioning Service Players Market Share by Revenue in 2025
- 5.6.3 2025 Pharmaceutical Decommissioning Service Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 KDC Veolia
- 6.1.1 KDC Veolia Company Information
- 6.1.2 KDC Veolia Business Overview
- 6.1.3 KDC Veolia Pharmaceutical Decommissioning Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 KDC Veolia Pharmaceutical Decommissioning Service Product Portfolio
- 6.1.5 KDC Veolia Recent Developments
- 6.2 RCS Pharma
- 6.2.1 RCS Pharma Company Information
- 6.2.2 RCS Pharma Business Overview
- 6.2.3 RCS Pharma Pharmaceutical Decommissioning Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 RCS Pharma Pharmaceutical Decommissioning Service Product Portfolio
- 6.2.5 RCS Pharma Recent Developments
- 6.3 Technical Safety Services
- 6.3.1 Technical Safety Services Company Information
- 6.3.2 Technical Safety Services Business Overview
- 6.3.3 Technical Safety Services Pharmaceutical Decommissioning Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Technical Safety Services Pharmaceutical Decommissioning Service Product Portfolio
- 6.3.5 Technical Safety Services Recent Developments
- 6.4 ISPE
- 6.4.1 ISPE Company Information
- 6.4.2 ISPE Business Overview
- 6.4.3 ISPE Pharmaceutical Decommissioning Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 ISPE Pharmaceutical Decommissioning Service Product Portfolio
- 6.4.5 ISPE Recent Developments
- 6.5 Brilliant Equipment Services
- 6.5.1 Brilliant Equipment Services Company Information
- 6.5.2 Brilliant Equipment Services Business Overview
- 6.5.3 Brilliant Equipment Services Pharmaceutical Decommissioning Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Brilliant Equipment Services Pharmaceutical Decommissioning Service Product Portfolio
- 6.5.5 Brilliant Equipment Services Recent Developments
- 6.6 Qualitech Environmental Services
- 6.6.1 Qualitech Environmental Services Company Information
- 6.6.2 Qualitech Environmental Services Business Overview
- 6.6.3 Qualitech Environmental Services Pharmaceutical Decommissioning Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Qualitech Environmental Services Pharmaceutical Decommissioning Service Product Portfolio
- 6.6.5 Qualitech Environmental Services Recent Developments
- 6.7 Hughes & Salvidge
- 6.7.1 Hughes & Salvidge Company Information
- 6.7.2 Hughes & Salvidge Business Overview
- 6.7.3 Hughes & Salvidge Pharmaceutical Decommissioning Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 Hughes & Salvidge Pharmaceutical Decommissioning Service Product Portfolio
- 6.7.5 Hughes & Salvidge Recent Developments
- 6.8 Divestiture
- 6.8.1 Divestiture Company Information
- 6.8.2 Divestiture Business Overview
- 6.8.3 Divestiture Pharmaceutical Decommissioning Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Divestiture Pharmaceutical Decommissioning Service Product Portfolio
- 6.8.5 Divestiture Recent Developments
- 6.9 Pharmagraph
- 6.9.1 Pharmagraph Company Information
- 6.9.2 Pharmagraph Business Overview
- 6.9.3 Pharmagraph Pharmaceutical Decommissioning Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 Pharmagraph Pharmaceutical Decommissioning Service Product Portfolio
- 6.9.5 Pharmagraph Recent Developments
- 6.10 RVA Group
- 6.10.1 RVA Group Company Information
- 6.10.2 RVA Group Business Overview
- 6.10.3 RVA Group Pharmaceutical Decommissioning Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 RVA Group Pharmaceutical Decommissioning Service Product Portfolio
- 6.10.5 RVA Group Recent Developments
- 6.11 DSM Demolition
- 6.11.1 DSM Demolition Company Information
- 6.11.2 DSM Demolition Business Overview
- 6.11.3 DSM Demolition Pharmaceutical Decommissioning Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 DSM Demolition Pharmaceutical Decommissioning Service Product Portfolio
- 6.11.5 DSM Demolition Recent Developments
- 6.12 KERAMIDA Inc
- 6.12.1 KERAMIDA Inc Company Information
- 6.12.2 KERAMIDA Inc Business Overview
- 6.12.3 KERAMIDA Inc Pharmaceutical Decommissioning Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.12.4 KERAMIDA Inc Pharmaceutical Decommissioning Service Product Portfolio
- 6.12.5 KERAMIDA Inc Recent Developments
- 6.13 Downwell Enabling Solutions
- 6.13.1 Downwell Enabling Solutions Company Information
- 6.13.2 Downwell Enabling Solutions Business Overview
- 6.13.3 Downwell Enabling Solutions Pharmaceutical Decommissioning Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.13.4 Downwell Enabling Solutions Pharmaceutical Decommissioning Service Product Portfolio
- 6.13.5 Downwell Enabling Solutions Recent Developments
7 North America
- 7.1 North America Pharmaceutical Decommissioning Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Pharmaceutical Decommissioning Service Market Size by Country (2021-2026)
- 7.3 North America Pharmaceutical Decommissioning Service Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Pharmaceutical Decommissioning Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Pharmaceutical Decommissioning Service Market Size by Country (2021-2026)
- 8.3 Europe Pharmaceutical Decommissioning Service Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Pharmaceutical Decommissioning Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Pharmaceutical Decommissioning Service Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Pharmaceutical Decommissioning Service Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Pharmaceutical Decommissioning Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Pharmaceutical Decommissioning Service Market Size by Country (2021-2026)
- 10.3 South America Pharmaceutical Decommissioning Service Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Pharmaceutical Decommissioning Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Pharmaceutical Decommissioning Service Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Pharmaceutical Decommissioning Service Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst